Immediate effects of milrinone on metabolic and sympathetic responses to exercise in severe congestive heart failure.

[1]  E. Braunwald,et al.  Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. , 1985, The Journal of clinical investigation.

[2]  J. Wilson,et al.  Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. , 1984, Circulation.

[3]  E. Sonnenblick,et al.  Should the failing heart be stimulated? , 1984, The New England journal of medicine.

[4]  Jack L. Martin,et al.  Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: role of cardiac pump dysfunction as determined by the effect of dobutamine. , 1984, The American journal of cardiology.

[5]  M. Sutton,et al.  Amrinone in the treatment of chronic cardiac failure. , 1984, Journal of the American College of Cardiology.

[6]  E. Sonnenblick,et al.  Acute inotropic stimulation with dopamine in severe congestive heart failure: beneficial hemodynamic effect at rest but not during maximal exercise. , 1983, The American journal of cardiology.

[7]  E. Braunwald,et al.  Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure. , 1983, The New England journal of medicine.

[8]  R. Ferrari,et al.  Cardiotonic Activity of Milrinone, a New and Potent Cardiac Bipyridine, on the Normal and Failing Heart of Experimental Animals , 1983, Journal of cardiovascular pharmacology.

[9]  G. Stankus,et al.  Characterization of the Cardiotonic Effects of Milrinone, a New and Potent Cardiac Bipyridine, on Isolated Tissues from Several Animal Species , 1983, Journal of cardiovascular pharmacology.

[10]  R. Magorien,et al.  Amrinone therapy for congestive heart failure in outpatients with idiopathic dilated cardiomyopathy. , 1983, The American journal of cardiology.

[11]  K. Weber,et al.  Effect of hydralazine on perfusion and metabolism in the leg during upright bicycle exercise in patients with heart failure. , 1983, Circulation.

[12]  M. Minami,et al.  Determination of anaerobic threshold for assessment of functional state in patients with chronic heart failure. , 1983, Circulation.

[13]  E. Sonnenblick,et al.  Sustained Hemodynamic and Clinical Effects of a New Cardiotonic Agent, WIN 47203, in Patients with Severe Congestive Heart Failure , 1983, Circulation.

[14]  B. Massie,et al.  Controlled Trial of Captopril in Chronic Heart Failure: A Rest and Exercise Hemodynamic Study , 1983, Circulation.

[15]  R. Magorien,et al.  Improved Exercise Capacity and Differing Arterial and Venous Tolerance During Chronic Isosorbide Dinitrate Therapy for Congestive Heart Failure , 1983, Circulation.

[16]  E. Sonnenblick,et al.  Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failure. , 1983, The American journal of cardiology.

[17]  J. Edelson,et al.  High-performance liquid chromatographic analysis of milrinone in plasma and urine. Intravenous pharmacokinetics in the dog. , 1983, Journal of chromatography.

[18]  A. Fishman,et al.  Oxygen Utilization and Ventilation During Exercise in Patients with Chronic Cardiac Failure , 1982, Circulation.

[19]  J. Cohn,et al.  Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. , 1982, The American journal of cardiology.

[20]  E. Sonnenblick,et al.  Acute Substantial Benefit of Inotropic Therapy with Amrinone on Exercise Hemodynamics and Metabolism in Severe Congestive Heart Failure , 1981, Circulation.

[21]  A. Fishman,et al.  Amrinone and exercise performance in patients with chronic heart failure. , 1981, The American journal of cardiology.

[22]  B J Whipp,et al.  Respiratory physiology of exercise: metabolism, gas exchange, and ventilatory control. , 1981, International review of physiology.

[23]  W. Parmley,et al.  Metabolic Assessment of Exercise in Chronic Heart Failure Patients: Treated with Short–term Vasodilators , 1980, Circulation.

[24]  E. Kinney,et al.  Hemodynamic and metabolic responses to upright exercise in patients with congestive heart failure. Treatment with nitroglycerin ointment. , 1979, Chest.

[25]  G. Y. Lesher,et al.  Cardiotonic Activity of Amrinone–Win 40680 [5‐Amino‐3,4f‐bipyridin‐6(lH)‐one] , 1979, Circulation research.

[26]  J. Franciosa,et al.  Immediate Effects of Hydralazine-Isosorbide Dinitrate Combination on Exercise Capacity and Exercise Hemodynamics in Patients with Left Ventricular Failure , 1979, Circulation.

[27]  J. Cohn,et al.  Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure. , 1979, The American journal of cardiology.

[28]  E. Braunwald,et al.  Hemodynamic assessment of amrinone. A new inotropic agent. , 1978, The New England journal of medicine.

[29]  A. Katz.  A new inotropic drug: its promise and a caution. , 1978, The New England journal of medicine.

[30]  J. Peuler,et al.  Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. , 1977, Life sciences.

[31]  J H Wilmore,et al.  An automated system for assessing metabolic and respiratory function during exercise. , 1976, Journal of applied physiology.

[32]  M. Stampfer,et al.  Impairment of Autonomically Mediated Heart Rate Control in Patients with Cardiac Dysfunction , 1975, Circulation research.

[33]  C. Consolazio,et al.  Physiological Measurements of Metabolic Functions in Man , 1963 .

[34]  E. Braunwald,et al.  Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure. , 1962, The New England journal of medicine.

[35]  W. M. Smith,et al.  The Response of the Abnormal Heart to Exercise , 1962, Circulation.